bupranolol and brl 37344

bupranolol has been researched along with brl 37344 in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (50.00)18.2507
2000's10 (45.45)29.6817
2010's1 (4.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blin, N; Camoin, L; Maigret, B; Strosberg, AD1
Guillaume, JL; Méjean, A; Strosberg, AD1
Berlan, M; Bousquet-Melou, A; Galitzky, J; Lafontan, M; Montastruc, JL1
Berlan, M; Carpéné, C; Galitzky, J; Lafontan, M; Portillo, M; Reverte, M1
Ichino, T; Koike, K; Koshikawa, H; Nagatomo, T; Takayanagi, I1
Bar-Ilan, A; Geyer, O; Lazar, M; Nachman, R; Oron, Y1
Gerhardt, CC; Gros, J; Issad, T; Strosberg, AD1
Atgié, C; Berlan, M; Carpéné, C; Fontana, E; Galitzky, J; Lafontan, M1
Horinouchi, T; Koike, K; Koshikawa, H1
Horinouchi, T; Koike, K5
Horinouchi, T; Koike, K; Tsujitani, M1
Brahmadevara, N; MacDonald, A; Shaw, AM1
Balligand, JL; Dessy, C; Ghisdal, P; Havaux, X; Moniotte, S; Noirhomme, P1
Canová, N; Farghali, H; Lincová, D1
Ivorra, MD; Leblais, V; Marthan, R; Muller, B; Pourageaud, F1
Doheny, HC; Lynch, CM; Morrison, JJ; Smith, TJ1
Clouse, AK; Hieble, JP; Riedel, E; Westfall, TD1
Jaroszewski, JJ; Markiewicz, W1

Other Studies

22 other study(ies) available for bupranolol and brl 37344

ArticleYear
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
    Molecular pharmacology, 1993, Volume: 44, Issue:6

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; GTP-Binding Proteins; Humans; Models, Molecular; Protein Conformation; Receptors, Adrenergic, beta; Signal Transduction; Structure-Activity Relationship

1993
Carazolol: a potent, selective beta 3-adrenoceptor agonist.
    European journal of pharmacology, 1995, Nov-30, Volume: 291, Issue:3

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dithiothreitol; Lipolysis; Propanolamines; Receptors, Adrenergic, beta

1995
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Bupranolol; Dioxoles; Dogs; Ethanolamines; Heart Rate; Isoproterenol; Male; Nitroprusside; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Regional Blood Flow; Skin

1994
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
    The American journal of physiology, 1993, Volume: 264, Issue:3 Pt 1

    Topics: Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Cell Membrane; Dogs; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Isoproterenol; Norepinephrine; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tetrahydronaphthalenes

1993
Beta3-adrenoceptors mediate relaxation of guinea pig taenia caecum by BRL37344A and BRL35135A.
    European journal of pharmacology, 1997, Sep-10, Volume: 334, Issue:2-3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Cecum; Dose-Response Relationship, Drug; Ethanolamines; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Phenethylamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3

1997
Beta3-adrenergic relaxation of bovine iris sphincter.
    FEBS letters, 1998, Jun-16, Volume: 429, Issue:3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Bupranolol; Cattle; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Ethanolamines; Iris; Isoproterenol; Muscle Relaxation; Muscle, Smooth; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3

1998
Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation.
    Molecular pharmacology, 1999, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Calcium-Calmodulin-Dependent Protein Kinases; CHO Cells; Colforsin; Cricetinae; Dioxoles; Enzyme Activation; Epinephrine; Ethanolamines; Humans; Insulin; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Norepinephrine; Phentolamine; Prazosin; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Signal Transduction; Yohimbine

1999
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 359, Issue:4

    Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adult; Animals; Binding, Competitive; Biogenic Amines; Bupranolol; CHO Cells; Cricetinae; Dioxoles; Dogs; Ethanolamines; Female; Gene Expression; Guinea Pigs; Humans; Imidazoles; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Lipolysis; Male; Mammals; Mesocricetus; Norepinephrine; Octopamine; Oxygen Consumption; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Species Specificity

1999
Effect of bupranolol for BRL37344 and noradrenaline-induced relaxations mediating atypical beta/beta3-adrenoceptor in rat oesophageal muscularis mucosae.
    General pharmacology, 1999, Volume: 33, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Esophagus; Ethanolamines; Male; Mucous Membrane; Muscle Relaxation; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3

1999
Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol.
    Pharmacology, 1999, Volume: 59, Issue:6

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bupranolol; Butoxamine; Catecholamines; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Gastric Fundus; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle Relaxation; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-3

1999
[Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastrointestinal tissue systems].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1999, Volume: 114 Suppl 1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Digestive System; Duodenum; Epinephrine; Ethanolamines; Gastric Fundus; Guinea Pigs; Ileum; Isoproterenol; Male; Muscle Relaxation; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta

1999
Partial agonist activity of carteolol on atypical beta-adrenoceptors in the guinea pig duodenum.
    European journal of pharmacology, 2000, Sep-01, Volume: 403, Issue:1-2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Carteolol; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vasodilator Agents

2000
(+/-)-Pindolol acts as a partial agonist at atypical beta-adrenoceptors in the guinea pig duodenum.
    Japanese journal of pharmacology, 2001, Volume: 85, Issue:1

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Duodenum; Ethanolamines; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta

2001
Functional identification of beta3-adrenoceptors in the guinea-pig ileum using the non-selective beta-adrenoceptor antagonist (+/-)-bupranolol.
    Journal of autonomic pharmacology, 2000, Volume: 20, Issue:4

    Topics: Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Dogs; Ethanolamines; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Propanolamines; Rats; Receptors, Adrenergic, beta-3

2000
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
    European journal of pharmacology, 2001, Mar-23, Volume: 416, Issue:1-2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism

2001
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
    British journal of pharmacology, 2004, Volume: 142, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Aorta, Thoracic; Binding Sites; Bupranolol; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanolamines; Imidazoles; Male; Muscle, Smooth, Vascular; Phenylephrine; Pindolol; Prazosin; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3; Tritium; United Kingdom; Vasoconstriction

2004
Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
    Circulation, 2004, Aug-24, Volume: 110, Issue:8

    Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Apamin; Arterioles; Bupranolol; Charybdotoxin; Child; Coronary Vessels; Endothelium, Vascular; Ethanolamines; Female; Humans; Isoproterenol; Male; Membrane Potentials; Microcirculation; Microscopy, Video; Middle Aged; Nadolol; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; RNA, Messenger; Vasodilation

2004
Inconsistent role of nitric oxide on lipolysis in isolated rat adipocytes.
    Physiological research, 2005, Volume: 54, Issue:4

    Topics: Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bucladesine; Bupranolol; Cell Separation; Cells, Cultured; Cyclic AMP; Ethanolamines; In Vitro Techniques; Lipolysis; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Donors; Proteins; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Tetrazolium Salts; Thiazoles

2005
Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.
    Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 371, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Ethanolamines; In Vitro Techniques; Ligands; Male; Propanolamines; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Adrenergic, beta-3; Vasodilation

2005
Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:10

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Dose-Response Relationship, Drug; Electrophysiology; Ethanolamines; Female; Humans; In Vitro Techniques; Isometric Contraction; Membrane Potentials; Muscle Cells; Muscle Relaxation; Myometrium; Oxytocin; Peptides; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Propanolamines; Receptors, Adrenergic, beta-3; Uterine Contraction; Uterus

2005
The effects and selectivity of beta-adrenoceptor agonists in rat myometrium and urinary bladder.
    European journal of pharmacology, 2007, Nov-14, Volume: 573, Issue:1-3

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Dose-Response Relationship, Drug; Ethanolamines; Female; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Myometrium; Oxytocics; Oxytocin; Potassium Chloride; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Ritodrine; Urinary Bladder; Uterine Contraction

2007
Influence of β2- and β3-adrenoceptor agonists on contractile activity of the porcine myometrium in the luteal phase and the first days of pregnancy.
    Polish journal of veterinary sciences, 2017, Mar-28, Volume: 20, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Albuterol; Animals; Bupranolol; Butoxamine; Corpus Luteum; Drug Interactions; Ethanolamines; Female; Myometrium; Pregnancy; Pregnancy, Animal; Swine; Uterine Contraction

2017